Santorini Scientific extend partnerships with internship at Imperial

May 25, 2022

Exploring TReg therapy to reduce post-transplant rejection

This summer, Santorini Scientific will be co-funding an internship with Imperial College London on Regulatory T-cell (TReg) therapy.


As the name suggests, TRegs are responsible for regulating immune responses therefore can be used to reduce autoimmune responses such as in cancer or, theoretically, rejection following a heart transplant.

15 Jun, 2023
After a competitive process, project funding has been awarded by Innovate UK to Santorini Scientific for modelling rejection as a platform for future post-transplant therapies
25 May, 2023
Developing a model for analysing heart transplant patient data
13 Apr, 2023
SSL secured AHSN Network Grant in Collaboration with the University of The West of England
05 Apr, 2023
Santorini Scientific is participating in a European scientific study funded by Horizon Europe to help the 2 million people in Europe affected by heart disease every year
09 Feb, 2023
Non-invasive Diagnostics will reduce patients’ stress factors and infection risks 
21 Dec, 2022
SSL is looking to purchase a 3D Bioprinter and technical support. Can you help? If so, please download and reply to our tender.
Santorini Scientific secure ERDF funding for a new Cardiac Diagnostics Project
27 Jun, 2022
27 June 2022: ERDF funding under the KEEP+ programme to work with UWE
Supporting trailblazing project at the University of Birmingham
17 May, 2022
17 May 2022: Post Graduate Taught (PGT) Knowledge Exchange Pathway (KEP)
Examining cardiac allograft vasculopathy
01 Jan, 2022
1 January 2022: Examining cardiac allograft vasculopathy
by Santorini Scientific 14 Dec, 2021
14 Dec 2021: Rejection is the biggest problem for those who receive a heart transplant
More posts
Share by: